1887

Chapter 37 : Molecular Approaches for Diagnosis of Malaria and the Characterization of Genetic Markers for Drug Resistance

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Molecular Approaches for Diagnosis of Malaria and the Characterization of Genetic Markers for Drug Resistance, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819071/9781555819088.ch37-1.gif /docserver/preview/fulltext/10.1128/9781555819071/9781555819088.ch37-2.gif

Abstract:

Human malaria is caused by infection with protozoan parasites of the genus Four species of are well known to cause malaria in humans: , , , and (with two subspecies, and [1]). Recently, a fifth species has been added to the list: the simian malaria species has been discovered to be a major cause of zoonotic human malaria in parts of Southeast Asia (2). The parasite species vary in the severity of disease they cause, as a result of differences in their biology, with the highest morbidity and mortality resulting from infection with . Correct identification of the infecting species is required to select appropriate and effective antimalarial drugs for treatment.

Citation: Ranford-Cartwright L, Ciuffreda L. 2016. Molecular Approaches for Diagnosis of Malaria and the Characterization of Genetic Markers for Drug Resistance, p 516-529. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch37
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

(A) Thick and (B) thin blood films showing ring forms. (Images taken from the Public Health Image Library, Centers for Disease Control and Prevention, courtesy CDC/Dr. Mae Melvin [public domain image]).

Citation: Ranford-Cartwright L, Ciuffreda L. 2016. Molecular Approaches for Diagnosis of Malaria and the Characterization of Genetic Markers for Drug Resistance, p 516-529. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch37
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

NASBA. Reprinted from ( ) with permission of the publisher.

Citation: Ranford-Cartwright L, Ciuffreda L. 2016. Molecular Approaches for Diagnosis of Malaria and the Characterization of Genetic Markers for Drug Resistance, p 516-529. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch37
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Schematic representation of the mechanism of LAMP. Reprinted from ( ) with permission of the publisher.

Citation: Ranford-Cartwright L, Ciuffreda L. 2016. Molecular Approaches for Diagnosis of Malaria and the Characterization of Genetic Markers for Drug Resistance, p 516-529. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch37
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819071.ch37
1. Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, Dolecek C, Hien TT, do Rosário VE, Arez AP, Pinto J, Michon P, Escalante AA, Nosten F, Burke M, Lee R, Blaze M, Otto TD, Barnwell JW, Pain A, Williams J, White NJ, Day NP, Snounou G, Lockhart PJ, Chiodini PL, Imwong M, Polley SD. 2010. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis 201:15441550.[CrossRef][PubMed]
2. Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, Thomas A, Conway DJ. 2004. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 363:10171024.[CrossRef][PubMed]
3. World Health Organization. 2010. Guidelines for the Treatment of Malaria. World Health Organization, Geneva, Switzerland.
4. World Health Organization. 2012. T3. Test. Treat. Track. Scaling Up Diagnostic Testing, Treatment and Surveillance for Malaria. World Health Organization, Geneva, Switzerland.
5. World Health Organization. 2013. World Malaria Report 2013. World Health Organization, Geneva, Switzerland.
6. The malERA Consultative Group on Diagnoses and Diagnostics. 2011. A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med 8:e1000396.
7. Ochola LB, Vounatsou P, Smith T, Mabaso ML, Newton CR. 2006. The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence of a gold standard. Lancet Infect Dis 6:582588.[CrossRef][PubMed]
8. World Health Organization.2010. Basic Malaria Microscopy, 2nd ed. Part 1: Learner's Guide. World Health Organization, Geneva, Switzerland.
9. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH. 2007. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 77(Suppl):119127.[PubMed]
10. Richards DF, Hunter DT, Janis B. 1969. Detection of plasmodia by acridine orange stain. Tech Bull Regist Med Technol 39:47.[PubMed]
11. Wardlaw SC, Levine RA. 1983. Quantitative buffy coat analysis. A new laboratory tool functioning as a screening complete blood cell count. JAMA 249:617620.[CrossRef][PubMed]
12. Spielman A, Perrone JB, Teklehaimanot A, Balcha F, Wardlaw SC, Levine RA. 1988. Malaria diagnosis by direct observation of centrifuged samples of blood. Am J Trop Med Hyg 39:337342.[PubMed]
13. Rickman LS, Long GW, Oberst R, Cabanban A, Sangalang R, Smith JI, Chulay JD, Hoffman SL. 1989. Rapid diagnosis of malaria by acridine orange staining of centrifuged parasites. Lancet 1:6871.[CrossRef][PubMed]
14. World Health Organization. 2006. Towards quality testing of malaria rapid diagnostic tests: evidence and methods. Proceedings of the WHO Informal Consultation on Development and Methods for Testing Malaria Rapid Diagnostic Tests. World Health Organization, Geneva, Switzerland.
15. Piper R, Lebras J, Wentworth L, Hunt-Cooke A, Houzé S, Chiodini P, Makler M. 1999. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am J Trop Med Hyg 60:109118.[PubMed]
16. Brown WM, Yowell CA, Hoard A, Vander Jagt TA, Hunsaker LA, Deck LM, Royer RE, Piper RC, Dame JB, Makler MT, Vander Jagt DL. 2004. Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites. Biochemistry 43:62196229.[CrossRef][PubMed]
17. Foster D, Cox-Singh J, Mohamad DS, Krishna S, Chin PP, Singh B. 2014. Evaluation of three rapid diagnostic tests for the detection of human infections with Plasmodium knowlesi. Malar J 13:60.[CrossRef][PubMed]
18. Barber BE, William T, Grigg MJ, Piera K, Yeo TW, Anstey NM. 2013. Evaluation of the sensitivity of a pLDH-based and an aldolase-based rapid diagnostic test for diagnosis of uncomplicated and severe malaria caused by PCR-confirmed Plasmodium knowlesi, Plasmodium falciparum, and Plasmodium vivax. J Clin Microbiol 51:11181123.[CrossRef][PubMed]
19. Rock EP, Marsh K, Saul AJ, Wellems TE, Taylor DW, Maloy WL, Howard RJ. 1987. Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology 95:209227.[CrossRef][PubMed]
20. Laferi H, Kandel K, Pichler H. 1997. False positive dipstick test for malaria. N Engl J Med 337:16351636.[CrossRef][PubMed]
21. Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, Incardona S, Perkins M, Bell D, McCarthy J, Cheng Q. 2010. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One 5:e8091.[CrossRef][PubMed]
22. Maltha J, Gamboa D, Bendezu J, Sanchez L, Cnops L, Gillet P, Jacobs J. 2012. Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions. PLoS One 7:e43094.[CrossRef][PubMed]
23. Koita OA, Doumbo OK, Ouattara A, Tall LK, Konaré A, Diakité M, Diallo M, Sagara I, Masinde GL, Doumbo SN, Dolo A, Tounkara A, Traoré I, Krogstad DJ. 2012. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg 86:194198.[CrossRef][PubMed]
24. Grobusch MP, Alpermann U, Schwenke S, Jelinek T, Warhurst DC. 1999. False-positive rapid tests for malaria in patients with rheumatoid factor. Lancet 353:297.[CrossRef][PubMed]
25. Leshem E, Keller N, Guthman D, Grossman T, Solomon M, Marva E, Schwartz E. 2011. False-positive Plasmodium falciparum histidine-rich protein 2 immunocapture assay results for acute schistosomiasis caused by Schistosoma mekongi. J Clin Microbiol 49:23312332.[CrossRef][PubMed]
26. Gillet P, Mumba Ngoyi D, Lukuka A, Kande V, Atua B, van Griensven J, Muyembe JJ, Jacobs J, Lejon V. 2013. False positivity of non-targeted infections in malaria rapid diagnostic tests: the case of human african trypanosomiasis. PLoS Negl Trop Dis 7:e2180.[CrossRef][PubMed]
27. Cloonan N, Fischer K, Cheng Q, Saul A. 2001. Aldolase genes of Plasmodium species. Mol Biochem Parasitol 113:327330.[CrossRef][PubMed]
28. World Health Organization. 2011. Malaria Rapid Diagnostic Test Performance: Summary Results of WHO Malaria RDT Product Testing: Rounds 1–3 (2008–2011). World Health Organization, Geneva, Switzerland.
29. Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P. 2011. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev 12:CD008122.[PubMed]
30. Baker J, Ho MF, Pelecanos A, Gatton M, Chen N, Abdullah S, Albertini A, Ariey F, Barnwell J, Bell D, Cunningham J, Djalle D, Echeverry DF, Gamboa D, Hii J, Kyaw MP, Luchavez J, Membi C, Menard D, Murillo C, Nhem S, Ogutu B, Onyor P, Oyibo W, Wang SQ, McCarthy J, Cheng Q. 2010. Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J 9:129.[CrossRef][PubMed]
31. Chiodini PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK, Luchavez J, Moody AH, Cenizal A, Bell D. 2007. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans R Soc Trop Med Hyg 101:331337.[CrossRef][PubMed]
32. Babiker HA, Abdel-Muhsin AM, Ranford-Cartwright LC, Satti G, Walliker D. 1998. Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am J Trop Med Hyg 59:582590.[PubMed]
33. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, Sauerwein RW. 2007. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg 76:470474.[PubMed]
34. McMorrow ML, Aidoo M, Kachur SP. 2011. Malaria rapid diagnostic tests in elimination settings—can they find the last parasite? Clin Microbiol Infect 17:16241631.[CrossRef][PubMed]
35. Mølle I, Petersen E, Buhl MR, Ingolf Mølle, Eskild Petersen, Mads. 1999. Retrospective evaluation of exposure to P. falciparum using antibodies to circumsporozoite protein and to cultured P. falciparum antigens. Scand J Infect Dis 31:6971.[CrossRef][PubMed]
36. Escalante AA, Goldman IF, De Rijk P, De Wachter R, Collins WE, Qari SH, Lal AA. 1997. Phylogenetic study of the genus Plasmodium based on the secondary structure-based alignment of the small subunit ribosomal RNA. Mol Biochem Parasitol 90:317321.[CrossRef][PubMed]
37. Waters AP, Higgins DG, McCutchan TF. 1991. Plasmodium falciparum appears to have arisen as a result of lateral transfer between avian and human hosts. Proc Natl Acad Sci USA 88:31403144.[CrossRef][PubMed]
38. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN. 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61:315320.[CrossRef][PubMed]
39. Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA. 1999. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg 60:687692.[PubMed]
40. Snounou G, Singh B. 2002. Nested PCR analysis of Plasmodium parasites. Methods Mol Med 72:189203.[PubMed]
41. Tham JM, Lee SH, Tan TM, Ting RC, Kara UA. 1999. Detection and species determination of malaria parasites by PCR: comparison with microscopy and with ParaSight-F and ICT malaria Pf tests in a clinical environment. J Clin Microbiol 37:12691273.[PubMed]
42. Steenkeste N, Incardona S, Chy S, Duval L, Ekala MT, Lim P, Hewitt S, Sochantha T, Socheat D, Rogier C, Mercereau-Puijalon O, Fandeur T, Ariey F. 2009. Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J 8:86.[CrossRef][PubMed]
43. Arai M, Mizukoshi C, Kubochi F, Kakutani T, Wataya Y. 1994. Detection of Plasmodium falciparum in human blood by a nested polymerase chain reaction. Am J Trop Med Hyg 51:617626.[PubMed]
44. Sethabutr O, Brown AE, Panyim S, Kain KC, Webster HK, Echeverria P. 1992. Detection of Plasmodium falciparum by polymerase chain reaction in a field study. J Infect Dis 166:145148.[CrossRef][PubMed]
45. Kain KC, Brown AE, Mirabelli L, Webster HK. 1993. Detection of Plasmodium vivax by polymerase chain reaction in a field study. J Infect Dis 168:13231326.[CrossRef][PubMed]
46. Filisetti D, Bombard S, N'Guiri C, Dahan R, Molet B, Abou-Bacar A, Hansmann Y, Christmann D, Candolfi E. 2002. Prospective assessment of a new polymerase chain reaction target (STEVOR) for imported Plasmodium falciparum malaria. Eur J Clin Microbiol Infect Dis 21:679681.[CrossRef][PubMed]
47. Mercereau-Puijalon O, Barale JC, Bischoff E. 2002. Three multigene families in Plasmodium parasites: facts and questions. Int J Parasitol 32:13231344.[CrossRef][PubMed]
48. McCutchan TF, de la Cruz VF, Lal AA, Gunderson JH, Elwood HJ, Sogin ML. 1988. Primary sequences of two small subunit ribosomal RNA genes from Plasmodium falciparum. Mol Biochem Parasitol 28:6368.[CrossRef][PubMed]
49. Li J, Gutell RR, Damberger SH, Wirtz RA, Kissinger JC, Rogers MJ, Sattabongkot J, McCutchan TF. 1997. Regulation and trafficking of three distinct 18 S ribosomal RNAs during development of the malaria parasite. J Mol Biol 269:203213.[CrossRef][PubMed]
50. Incardona S, Chy S, Chiv L, Nhem S, Sem R, Hewitt S, Doung S, Mercereau-Puijalon O, Fandeur T. 2005. Large sequence heterogeneity of the small subunit ribosomal RNA gene of Plasmodium ovale in cambodia. Am J Trop Med Hyg 72:719724.[PubMed]
51. Kawamoto F, Miyake H, Kaneko O, Kimura M, Nguyen TD, Nguyen TD, Liu Q, Zhou M, Le DD, Kawai S, Isomura S, Wataya Y. 1996. Sequence variation in the 18S rRNA gene, a target for PCR-based malaria diagnosis, in Plasmodium ovale from southern Vietnam. J Clin Microbiol 34:22872289.[PubMed]
52. Liu Q, Zhu S, Mizuno S, Kimura M, Liu P, Isomura S, Wang X, Kawamoto F. 1998. Sequence variation in the small-subunit rRNA gene of Plasmodium malariae and prevalence of isolates with the variant sequence in Sichuan, China. J Clin Microbiol 36:33783381.[PubMed]
53. Snounou G. 1996. Detection and identification of the four malaria parasite species infecting humans by PCR amplification. Methods Mol Biol 50:263291.[PubMed]
54. Rubio JM, Benito A, Roche J, Berzosa PJ, García ML, Micó M, Edú M, Alvar J. 1999. Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. Am J Trop Med Hyg 60:183187.[PubMed]
55. Kho WG, Chung JY, Sim EJ, Kim MY, Kim DW, Jongwutiwes S, Tanabe K. 2003. A multiplex polymerase chain reaction for a differential diagnosis of Plasmodium falciparum and Plasmodium vivax. Parasitol Int 52:229236.[CrossRef][PubMed]
56. Padley D, Moody AH, Chiodini PL, Saldanha J. 2003. Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Ann Trop Med Parasitol 97:131137.[CrossRef][PubMed]
57. Patsoula E, Spanakos G, Sofianatou D, Parara M, Vakalis NC. 2003. A single-step, PCR-based method for the detection and differentiation of Plasmodium vivax and P. falciparum. Ann Trop Med Parasitol 97:1521.[CrossRef][PubMed]
58. Chew CH, Lim YA, Lee PC, Mahmud R, Chua KH. 2012. Hexaplex PCR detection system for identification of five human Plasmodium species with an internal control. J Clin Microbiol 50:40124019.[CrossRef][PubMed]
59. Wilson RJ, Williamson DH. 1997. Extrachromosomal DNA in the Apicomplexa. Microbiol Mol Biol Rev 61:116.[PubMed]
60. Preiser PR, Wilson RJ, Moore PW, McCready S, Hajibagheri MA, Blight KJ, Strath M, Williamson DH. 1996. Recombination associated with replication of malarial mitochondrial DNA. EMBO J 15:684693.[PubMed]
61. Krungkrai J. 2004. The multiple roles of the mitochondrion of the malarial parasite. Parasitology 129:511524.[CrossRef][PubMed]
62. Haanshuus CG, Mohn SC, Mørch K, Langeland N, Blomberg B, Hanevik K. 2013. A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway. Malar J 12:26.[CrossRef][PubMed]
63. Taylor LH, Read AF. 1997. Why so few transmission stages? Reproductive restraint by malaria parasites. Parasitol Today 13:135140.[CrossRef][PubMed]
64. Polley SD, Mori Y, Watson J, Perkins MD, González IJ, Notomi T, Chiodini PL, Sutherland CJ. 2010. Mitochondrial DNA targets increase sensitivity of malaria detection using loop-mediated isothermal amplification. J Clin Microbiol 48:28662871.[CrossRef][PubMed]
65. Okell LC, Ghani AC, Lyons E, Drakeley CJ. 2009. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis 200:15091517.[CrossRef][PubMed]
66. Bødker R, Msangeni HA, Kisinza W, Lindsay SW. 2006. Relationship between the intensity of exposure to malaria parasites and infection in the Usambara Mountains, Tanzania. Am J Trop Med Hyg 74:716723.[PubMed]
67. Snounou G, Pinheiro L, Gonçalves A, Fonseca L, Dias F, Brown KN, do Rosario VE. 1993. The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bissau. Trans R Soc Trop Med Hyg 87:649653.[CrossRef][PubMed]
68. Mayxay M, Pukrittayakamee S, Newton PN, White NJ. 2004. Mixed-species malaria infections in humans. Trends Parasitol 20:233240.[CrossRef][PubMed]
69. Zimmerman PA, Mehlotra RK, Kasehagen LJ, Kazura JW. 2004. Why do we need to know more about mixed Plasmodium species infections in humans? Trends Parasitol 20:440447.[CrossRef][PubMed]
70. Hänscheid T, Grobusch MP. 2002. How useful is PCR in the diagnosis of malaria? Trends Parasitol 18:395398.[CrossRef][PubMed]
71. Lee MA, Tan CH, Aw LT, Tang CS, Singh M, Lee SH, Chia HP, Yap EP. 2002. Real-time fluorescence-based PCR for detection of malaria parasites. J Clin Microbiol 40:43434345.[CrossRef][PubMed]
72. Hermsen CC, Telgt DS, Linders EH, van de Locht LA, Eling WM, Mensink EJ, Sauerwein RW. 2001. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol 118:247251.[CrossRef][PubMed]
73. de Monbrison F, Angei C, Staal A, Kaiser K, Picot S. 2003. Simultaneous identification of the four human Plasmodium species and quantification of Plasmodium DNA load in human blood by real-time polymerase chain reaction. Trans R Soc Trop Med Hyg 97:387390.[CrossRef][PubMed]
74. Murphy SC, Prentice JL, Williamson K, Wallis CK, Fang FC, Fried M, Pinzon C, Wang R, Talley AK, Kappe SH, Duffy PE, Cookson BT. 2012. Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials. Am J Trop Med Hyg 86:383394.[CrossRef][PubMed]
75. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455467.[CrossRef][PubMed]
76. Compton J. 1991. Nucleic acid sequence-based amplification. Nature 350:9192.[CrossRef][PubMed]
77. Chan AB, Fox JD. 1999. NASBA and other transcription-based amplification methods for research and diagnostic micro-biology. Rev Med Microbiol 10:185196.
78. Schoone GJ, Oskam L, Kroon NC, Schallig HD, Omar SA. 2000. Detection and quantification of Plasmodium falciparum in blood samples using quantitative nucleic acid sequence-based amplification. J Clin Microbiol 38:40724075.[PubMed]
79. Mens PF, Schoone GJ, Kager PA, Schallig HD. 2006. Detection and identification of human Plasmodium species with real-time quantitative nucleic acid sequence-based amplification. Malar J 5:80.[CrossRef][PubMed]
80. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. 2000. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28:E63.[CrossRef][PubMed]
81. Nagamine K, Hase T, Notomi T. 2002. Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes 16:223229.[CrossRef][PubMed]
82. Hopkins H, González IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C, Agaba B, Kyabayinze DJ, Sutherland CJ, Perkins MD, Bell D. 2013. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis 208:645652.[CrossRef][PubMed]
83. Mori Y, Nagamine K, Tomita N, Notomi T. 2001. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res Commun 289:150154.[CrossRef][PubMed]
84. Tomita N, Mori Y, Kanda H, Notomi T. 2008. Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products. Nat Protoc 3:877882.[CrossRef][PubMed]
85. Poon LL, Wong BW, Ma EH, Chan KH, Chow LM, Abeyewickreme W, Tangpukdee N, Yuen KY, Guan Y, Looareesuwan S, Peiris JS. 2006. Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin Chem 52:303306.[CrossRef][PubMed]
86. Han ET, Watanabe R, Sattabongkot J, Khuntirat B, Sirichaisinthop J, Iriko H, Jin L, Takeo S, Tsuboi T. 2007. Detection of four Plasmodium species by genus- and species-specific loop-mediated isothermal amplification for clinical diagnosis. J Clin Microbiol 45:25212528.[CrossRef][PubMed]
87. Paris DH, Imwong M, Faiz AM, Hasan M, Yunus EB, Silamut K, Lee SJ, Day NP, Dondorp AM. 2007. Loop-mediated isothermal PCR (LAMP) for the diagnosis of falciparum malaria. Am J Trop Med Hyg 77:972976.[PubMed]
88. Iseki H, Kawai S, Takahashi N, Hirai M, Tanabe K, Yokoyama N, Igarashi I. 2010. Evaluation of a loop-mediated isothermal amplification method as a tool for diagnosis of infection by the zoonotic simian malaria parasite Plasmodium knowlesi. J Clin Microbiol 48:25092514.[CrossRef][PubMed]
89. Lau YL, Fong MY, Mahmud R, Chang PY, Palaeya V, Cheong FW, Chin LC, Anthony CN, Al-Mekhlafi AM, Chen Y. 2011. Specific, sensitive and rapid detection of human plasmodium knowlesi infection by loop-mediated isothermal amplification (LAMP) in blood samples. Malar J 10:197.[CrossRef][PubMed]
90. Buates S, Bantuchai S, Sattabongkot J, Han ET, Tsuboi T, Udomsangpetch R, Sirichaisinthop J, Tan-ariya P. 2010. Development of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) for clinical detection of Plasmodium falciparum gametocytes. Parasitol Int 59:414420.[CrossRef][PubMed]
91. Bruce MC, Carter RN, Nakamura K, Aikawa M, Carter R. 1994. Cellular location and temporal expression of the Plasmodium falciparum sexual stage antigen Pfs16. Mol Biochem Parasitol 65:1122.[CrossRef][PubMed]
92. Kumar N, Carter R. 1985. Biosynthesis of two stage-specific membrane proteins during transformation of Plasmodium gallinaceum zygotes into ookinetes. Mol Biochem Parasitol 14:127139.[CrossRef][PubMed]
93. Laoboonchai A, Kawamoto F, Thanoosingha N, Kojima S, Scott Miller RR, Kain KC, Wongsrichanalai C. 2001. PCR-based ELISA technique for malaria diagnosis of specimens from Thailand. Trop Med Int Health 6:458462.[CrossRef][PubMed]
94. McNamara DT, Thomson JM, Kasehagen LJ, Zimmerman PA. 2004. Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by the four parasite species causing malaria in humans. J Clin Microbiol 42:24032410.[CrossRef][PubMed]
95. Swan H, Sloan L, Muyombwe A, Chavalitshewinkoon-Petmitr P, Krudsood S, Leowattana W, Wilairatana P, Looareesuwan S, Rosenblatt J. 2005. Evaluation of a real-time polymerase chain reaction assay for the diagnosis of malaria in patients from Thailand. Am J Trop Med Hyg 73:850854.[PubMed]
96. Mens PF, van Amerongen A, Sawa P, Kager PA, Schallig HD. 2008. Molecular diagnosis of malaria in the field: development of a novel 1-step nucleic acid lateral flow immunoassay for the detection of all 4 human Plasmodium spp. and its evaluation in Mbita, Kenya. Diagn Microbiol Infect Dis 61:421427.[CrossRef][PubMed]
97. Gascoyne P, Satayavivad J, Ruchirawat M. 2004. Microfluidic approaches to malaria detection. Acta Trop 89:35736.9[CrossRef][PubMed]
98. Miller LH, Usami S, Chien S. 1971. Alteration in the rheologic properties of Plasmodium knowlesi—infected red cells. A possible mechanism for capillary obstruction. J Clin Invest 50:14511455.[CrossRef][PubMed]
99. Miller LH, Chien S, Usami S. 1972. Decreased deformability of Plasmodium coatneyi-infected red cells and its possible relation to cerebral malaria. Am J Trop Med Hyg 21:133137.[PubMed]
100. Nash GB, O'Brien E, Gordon-Smith EC, Dormandy JA. 1989. Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum. Blood 74:855861.[PubMed]
101. Cranston HA, Boylan CW, Carroll GL, Sutera SP, Williamson JR, Gluzman IY, Krogstad DJ. 1984. Plasmodium falciparum maturation abolishes physiologic red cell deformability. Science 223:400403.[CrossRef][PubMed]
102. Glenister FK, Coppel RL, Cowman AF, Mohandas N, Cooke BM. 2002. Contribution of parasite proteins to altered mechanical properties of malaria-infected red blood cells. Blood 99:10601063.[CrossRef][PubMed]
103. Mills JP, Diez-Silva M, Quinn DJ, Dao M, Lang MJ, Tan KS, Lim CT, Milon G, David PH, Mercereau-Puijalon O, Bonnefoy S, Suresh S. 2007. Effect of plasmodial RESA protein on deformability of human red blood cells harboring Plasmodium falciparum. Proc Natl Acad Sci USA 104:92139217.[CrossRef][PubMed]
104. Guo Q, Reiling SJ, Rohrbach P, Ma H. 2012. Microfluidic biomechanical assay for red blood cells parasitized by Plasmodium falciparum. Lab Chip 12:11431150[CrossRef].[PubMed]
105. Geislinger TM, Chan S, Moll K, Wixforth A, Wahlgren M, Franke T. 2014. Label-free microfluidic enrichment of ring-stage Plasmodium falciparum-infected red blood cells using non-inertial hydrodynamic lift. Malar J 13:375.[CrossRef][PubMed]
106. Aceti A, Bonincontro A, Cametti C, Celestino D, Leri O. 1990. Electrical conductivity of human erythrocytes infected with Plasmodium falciparum and its modification following quinine therapy. Trans R Soc Trop Med Hyg 84:671672.[CrossRef][PubMed]
107. Gascoyne P, Pethig R, Satayavivad J, Becker FF, Ruchirawat M. 1997. Dielectrophoretic detection of changes in erythrocyte membranes following malarial infection. Biochim Biophys Acta 1323:240252.[CrossRef][PubMed]
108. Pohl HA. 1978. Dielectrophoresis: The Behaviour of Neutral Matter in Non-Uniform Electric Fields. Cambridge University Press, New York, NY.
109. Gascoyne P, Mahidol C, Ruchirawat M, Satayavivad J, Watcharasit P, Becker F. 2002. Microsample preparation by dielectrophoresis: isolation of malaria. Lab Chip 2:7075.[CrossRef][PubMed]
110. Gascoyne PR, Vykoukal J. 2002. Particle separation by dielectrophoresis. Electrophoresis 23:19731983.[CrossRef][PubMed]
111. Friend J, Yeo LY. 2011. Microscale acoustofluidics: microfluidics driven via acoustics and ultrasonics. Rev Mod Phys 83:647704.[CrossRef]
112. Bourquin Y, Syed A, Reboud J, Ranford-Cartwright LC, Barrett MP, Cooper JM. 2014. Rare-cell enrichment by a rapid, label-free, ultrasonic isopycnic technique for medical diagnostics. Angew Chem Int Ed Engl 53:55875590.[CrossRef][PubMed]
113. Reboud J, Bourquin Y, Wilson R, Pall GS, Jiwaji M, Pitt AR, Graham A, Waters AP, Cooper JM. 2012. Shaping acoustic fields as a toolset for microfluidic manipulations in diagnostic technologies. Proc Natl Acad Sci USA 109:1516215167.[CrossRef][PubMed]
114. Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. 2014. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 14:982991.[CrossRef][PubMed]
115. Fernando D, Rodrigo C, Rajapakse S. 2011. Primaquine in vivax malaria: an update and review on management issues. Malar J 10:351.[CrossRef][PubMed]
116. World Health Organization. 2010. Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000–2010. WHO Press, Geneva, Switzerland.
117. World Health Organization. 1990. In vitro Microtest (Mark II) for the Assessment of Response of Plasmodium falciparum to Chloroquine, Mefloquine, Quinine, Sulfadoxine/Pyrimethamine and Amodiaquine. WHO document MAP/87.2, Rev. 1 World Health Organization, Geneva, Switzerland.
118. World Health Organization. 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. WHO/HTM/RBM/2003.50 World Health Organization, Geneva, Switzerland.
119. Basco LK. 2007. Field Application of In Vitro Assays for the Sensitivity of Human Malaria Parasites to Antimalarial Drugs. World Health Organization, Geneva, Switzerland.
120. Mwangi JM, Ranford-Cartwright LC. 2013. Genetic and genomic approaches for the discovery of parasite genes involved in antimalarial drug resistance. Parasitology 140:14551467.[CrossRef][PubMed]
121. Cravo P, Culleton R, Hunt P, Walliker D, Mackinnon MJ. 2001. Antimalarial drugs clear resistant parasites from partially immune hosts. Antimicrob Agents Chemother 45:28972901.[CrossRef][PubMed]
122. Diakite M, Achidi EA, Achonduh O, Craik R, Djimde AA, Evehe MS, Green A, Hubbart C, Ibrahim M, Jeffreys A, Khan BK, Kimani F, Kwiatkowski DP, Mbacham WF, Jezan SO, Ouedraogo JB, Rockett K, Rowlands K, Tagelsir N, Tekete MM, Zongo I, Ranford-Cartwright LC. 2011. Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites. Malar J 10:250.[CrossRef][PubMed]
123. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK. 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176:15901596.[CrossRef][PubMed]
124. Kublin JG, Witzig RS, Shankar AH, Zurita JQ, Gilman RH, Guarda JA, Cortese JF, Plowe CV. 1998. Molecular assays for surveillance of antifolate-resistant malaria. Lancet 351:16291630.[CrossRef][PubMed]
125. Nzila-Mounda A, Mberu EK, Sibley CH, Plowe CV, Winstanley PA, Watkins WM. 1998. Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob Agents Chemother 42:164169.[PubMed]
126. Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RA, Chimpeni P, Molyneux ME, Taylor TE. 2004. Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. BMJ 328:545.[CrossRef][PubMed]
127. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, Chandramohan D, Sharp B. 2003. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 361:11741181.[CrossRef][PubMed]
128. Anderson TJ, Roper C. 2005. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop 94:269280.[CrossRef][PubMed]
129. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320323.[CrossRef][PubMed]
130. Hastings IM. 2004. The origins of antimalarial drug resistance. Trends Parasitol 20:512518.[CrossRef][PubMed]
131. Nomura T, Carlton JM, Baird JK, del Portillo HA, Fryauff DJ, Rathore D, Fidock DA, Su X, Collins WE, McCutchan TF, Wootton JC, Wellems TE. 2001. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis 183:16531661.[CrossRef][PubMed]
132. JM, Nomura T, Neves J, Baird JK, Wellems TE, del Portillo HA. 2005. Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains. Exp Parasitol 109:256259.[CrossRef][PubMed]
133. de Pécoulas PE, Tahar R, Ouatas T, Mazabraud A, Basco LK. 1998. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol Biochem Parasitol 92:265273.[CrossRef][PubMed]
134. Korsinczky M, Fischer K, Chen N, Baker J, Rieckmann K, Cheng Q. 2004. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. Antimicrob Agents Chemother 48:22142222.[CrossRef][PubMed]
135. Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh N, Maguire J, Bell D, O'Neil MT, Cheng Q. 2006. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am J Trop Med Hyg 75:617621.[PubMed]
136. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52:565568.[PubMed]
137. Eldin de Pécoulas P, Basco LK, Abdallah B, Djé MK, Le Bras J, Mazabraud A. 1995. Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Exp Parasitol 80:483487.[CrossRef][PubMed]
138. Duraisingh MT, Curtis J, Warhurst DC. 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol 89:18.[CrossRef][PubMed]
139. Zolg JW, Chen GX, Plitt JR. 1990. Detection of pyrimethamine resistance in Plasmodium falciparum by mutation-specific polymerase chain reaction. Mol Biochem Parasitol 39:257265.[CrossRef][PubMed]
140. Wang P, Brooks DR, Sims PF, Hyde JE. 1995. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 71:115125.[CrossRef][PubMed]
141. Abdel-Muhsin AM, Ranford-Cartwright LC, Medani AR, Ahmed S, Suleiman S, Khan B, Hunt P, Walliker D, Babiker HA. 2002. Detection of mutations in the Plasmodium falciparum dihydrofolate reductase (dhfr) gene by dot-blot hybridization. Am J Trop Med Hyg 67:2427.[PubMed]
142. Ranford-Cartwright LC, Johnston KL, Abdel-Muhsin AM, Khan BK, Babiker HA. 2002. Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum. Trans R Soc Trop Med Hyg 96:568572.[CrossRef][PubMed]
143. Wilson PE, Alker AP, Meshnick SR. 2005. Real-time PCR methods for monitoring antimalarial drug resistance. Trends Parasitol 21:278283.[CrossRef][PubMed]
144. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438447.[CrossRef][PubMed]
145. Mabey D, Peeling RW, Ustianowski A, Perkins MD. 2004. Diagnostics for the developing world. Nat Rev Microbiol 2:231240.[CrossRef][PubMed]
146. Weusten JJ, Carpay WM, Oosterlaken TA, van Zuijlen MC, van de Wiel PA. 2002. Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beacons. Nucleic Acids Res 30:e26.[CrossRef][PubMed]
147. Wellems TE, Walker-Jonah A, Panton LJ. 1991. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc Natl Acad Sci USA 88:33823386.[CrossRef][PubMed]
148. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6:861871.[CrossRef][PubMed]
149. Sidhu AB, Verdier-Pinard D, Fidock DA. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210213.[CrossRef][PubMed]
150. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF. 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255258.[CrossRef][PubMed]
151. Foote SJ, Galatis D, Cowman AF. 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87:30143017.[CrossRef][PubMed]
152. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ. 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 85:91099113.[CrossRef][PubMed]
153. Peterson DS, Walliker D, Wellems TE. 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85:91149118.[CrossRef][PubMed]
154. Peterson DS, Di Santi SM, Povoa M, Calvosa VS, Do Rosario VE, Wellems TE. 1991. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 45:492497.[PubMed]
155. Wang P, Read M, Sims PF, Hyde JE. 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol 23:979986.[CrossRef][PubMed]
156. Triglia T, Menting JG, Wilson C, Cowman AF. 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94:1394413949.[CrossRef][PubMed]
157. Srivastava IK, Morrisey JM, Darrouzet E, Daldal F, Vaidya AB. 1999. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol Microbiol 33:704711.[CrossRef][PubMed]
158. Schwöbel B, Alifrangis M, Salanti A, Jelinek T. 2003. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. Malar J 2:5.[CrossRef][PubMed]